glp 1 weight loss medication side effects GLP-1 Medications: Everything You Need to Know GI Adverse Effects of Glucagon-Like

Accessed June 2, 2026.

Pozzilli, P., Buzzetti, R., Frederich, R., Iqbal, N

These findings may aid clinicians to anticipate and manage these side effects earlier, especially in patients with baseline hypersomnia or sleep related disorders

PMID 21329779

doi: 10.1038/s41386-022-01297-2, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] Honma M., Kuroda T., Futamura A., Sugimoto A., Kawamura M

Avexitide is an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist that has been evaluated in five clinical trials for post-bariatric hypoglycemia (PBH) and has also been studied in congenital hyperinsulinism (HI), two indications characterized by hyperinsulinemic hypoglycemia